Micron Technology Announces Upcoming Investor Events
November 03, 2022 16:00 ET
|
Micron Technology, Inc.
BOISE, Idaho, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU), announced today that company executives will participate in fireside chats at the following investor events: ...
Finexio Closes $35 Million Series B Funding Round
October 24, 2022 08:00 ET
|
Finexio
ORLANDO, Fla., Oct. 24, 2022 (GLOBE NEWSWIRE) -- Finexio, the fast-growing B2B accounts payables (AP) Payments-as-a-Service company, today announces the successful completion of an oversubscribed...
Otonomo to Present at J.P. Morgan Automotive Conference in NYC
July 26, 2022 08:00 ET
|
OTONOMO TECHNOLOGIES LTD
HERZLIYA, Israel and SAN FRANCISCO, July 26, 2022 (GLOBE NEWSWIRE) -- Otonomo Technologies Ltd. (Nasdaq: OTMO), the platform powering the mobility economy, today announced that Ben Volkow will...
AFR Furniture Rental Closes on Recapitalization Transaction in Conjunction With J.P. Morgan Global Alternatives
January 10, 2022 13:00 ET
|
AFR Furniture Rental
PENNSAUKEN, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- AFR Furniture Rental is proud to announce a recapitalization transaction in conjunction with the Global Special Situations team of J.P. Morgan...
Coherus and Junshi Biosciences Expand Immuno-Oncology Collaboration to Include TIGIT-Targeted Antibody
January 10, 2022 07:30 ET
|
Coherus BioSciences, Inc.
• Coherus and Junshi Biosciences plan to evaluate the toripalimab + JS006 combinationin clinical trials in multiple tumor types • Combinations of PD-1 + TIGIT inhibitors have potential to expand...
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenue and Provides 2022 Revenue Outlook
January 09, 2022 18:00 ET
|
Rapid Micro Biosystems, Inc.
Full year 2021 commercial revenue expected to be between $21.3 million and $21.7 million Full year 2022 commercial revenue outlook between $27 million and $32 million Company to Present at the 40th...
Morphic Therapeutic to Present at the Virtual 40th Annual J.P. Morgan Healthcare Conference
January 05, 2022 08:00 ET
|
Morphic Therapeutic
WALTHAM, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious...
BioNTech präsentiert auf der 40. Annual J.P. Morgan Healthcare Conference
December 27, 2021 06:45 ET
|
BioNTech SE
MAINZ, Deutschland, 27. Dezember 2021 — BioNTech SE (Nasdaq: BNTX, „BioNTech” oder „das Unternehmen”) gab heute bekannt, dass CEO und Mitbegründer Prof. Dr. Ugur Sahin ein Unternehmensupdate auf der...
BioNTech to Present at the 40th Annual J.P. Morgan Healthcare Conference
December 27, 2021 06:45 ET
|
BioNTech SE
MAINZ, Germany, December 27, 2021 — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that CEO and Co-founder Ugur Sahin, M.D., will present a corporate overview and update at...
Micron Technology Announces Upcoming Investor Event
December 14, 2021 16:01 ET
|
Micron Technology, Inc.
BOISE, Idaho, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU), today announced Chief Financial Officer David Zinsner will take part in a fireside chat at the J.P. Morgan...